Comments

Taysha Gene Therapies

Q: What sector and industry does Taysha Gene Therapies (TSHA) operate in?

Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TSHANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q4 2024 Earnings in 5 days from now on Wed Feb 26th, before the market open

Conference call scheduled in 5 days at 8:30 AM Click to view the webcast

Taysha Gene Therapies (TSHA) Forecast

News Earnings Taysha Gene Therapies (TSHA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Want to View Edge Rankings?

Unlock The Hidden Results With Your Benzinga Account Now.

Get Started

Taysha Gene Therapies (NASDAQ:TSHA) Stock Quotes, Forecast and News Summary

Taysha Gene Therapies Stock (NASDAQ: TSHA) stock price, news, charts, stock research, profile.

Open	$1.65
Close	-
Volume / Avg.	235.64K / 3.16M
Day Range	$1.64 - $1.71
52 Wk Range	1.19 - 4.32
Market Cap	$335.08M
P/E Ratio	2.60
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	15.51%
Days to Cover	10.88

Recent News

Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

Neurogene (NASDAQ:NGNE) stock just took a sharp dive, plummeting 44% in a single day. Bad news on Monday caused the pharmaceutical company’s shares to drop massively in after-hours trading, and they continued to

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.65
Close	-
Volume / Avg.	235.64K / 3.16M
Day Range	$1.64 - $1.71
52 Wk Range	1.19 - 4.32
Market Cap	$335.08M
P/E Ratio	2.60
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	15.51%
Days to Cover	10.88

About Taysha Gene Therapies Inc

Sector

Health Care

Industry

Biotechnology

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disea...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Taysha Gene Therapies (TSHA) stock?

You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.

View our list of the best stock brokerages

Who are Taysha Gene Therapies (TSHA) competitors?

Other companies in Taysha Gene Therapies’s space includes: Tevogen Bio Holdings (NASDAQ:TVGN), aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE), Olema Pharmaceuticals (NASDAQ:OLMA) and Ironwood Pharmaceuticals (NASDAQ:IRWD).

What is the forecast, or price target, for Taysha Gene Therapies (TSHA) stock?

Taysha Gene Therapies has a consensus price target of $5.87.

What is the current price for Taysha Gene Therapies (TSHA)?

The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $1.635 last updated February 21, 2025 at 10:18 AM EST.

Does Taysha Gene Therapies (TSHA) pay a dividend?

There are no upcoming dividends for Taysha Gene Therapies.

When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?

Taysha Gene Therapies’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Taysha Gene Therapies (TSHA) going to split?

There is no upcoming split for Taysha Gene Therapies.

What sector and industry does Taysha Gene Therapies (TSHA) operate in?

Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.